Rakesh Jhunjhunwala raises stake in this pharma firm. Do you own?

Rakesh Jhunjhunwala, known as ‘Warren Buffett’ in India, has raised its shares with a certain point in the integrated global pharmaceutical company, Jubilant Pharmova. Also, his wife Rekha Jhunjhunwala’s stock has increased by a small portion of the company.Big Bull of Dalal Street, Rakesh managed his portfolio and his wife Rekha.

The fourth quarter of FY22 has become a busy period for Jhunjhunwala which makes significant profits in its portfolio. Investors have also been penetrated in their portfolio.So far, Jubilant Pharmova remains its biggest investment in Q4FY22. Many companies in their portfolio have not submitted their shareholding patterns for March Quarter 2022.

In accordance with the pattern of share ownership, Rakesh increases its shares to 57.5 shares of Lakh equity or 3.61% in Pharmova Jubilant during Q4FY22. This is higher than 50.2 lakh equity shares or 3.15% which he holds in the company during Q3FY22.Meanwhile, Holding Rekha has also jumped to 50.20 Equity Stocks Lakh or 3.15% in the company during Q4FY22 compared to 5 Lakh equity shares or 3.14% in Q3FY22.

Together, the share ownership of the pair in Jubilant Pharmova has increased by 0.47% at Q4FY22.Investors buy more shares in Pharmova Jubilant even though the company corrects steeply so far in a year. It displays that Jhunjhunwala is optimistic about Pharmova Jubilant forward.

On Tuesday, Pharmova Jubilant shares were closed on ₹ 461.75 each flat compared to the previous closure at BSE. At the latest stock price, the company’s market stands almost ₹ 7,355 crore.So far in 2022, Pharmova Jubilant shares have dipped almost 21%. Meanwhile, taking into account the closing price of Tuesday, the stock has dropped by around 40% in a year. Its shares are around ₹ 770 respectively on April 19 last year. In accordance with Trendlyne’s data, Jhunjhunwala holding in Jubilant Pharmova is on April 19, worth ₹ 498 Crore.

Rakesh has also increased its shares in Canara Bank by 0.36% at Q4FY22. While he lowered several shares in stocks such as Wockhardt, Aptech, Titan Company, Escorts, and Delta Corp.During Q4Fy22, the Jhunjhunwala portfolio skyrocketed with a very large 38% to ₹ 33,753.92 Crore compared to ₹ 24,449.2 Crore at Q3FY22. In the past year, his portfolio has recorded a 102% increase.

Leave a Reply

Your email address will not be published. Required fields are marked *